It’s the kind of news that’s no longer news.
Emergent BioSolutions, which manufactures
the Anthrax vaccine at a plant in Lansing, announced plans to eliminate 91
jobs, reducing the size of its labor force at this facility by 24 percent.
The reason? The company has installed a
newer manufacturing process that incorporates more automation, thus requiring
fewer workers. Previously, the plant produced nine million doses a year. Now,
with the new operational system, housed a newer facility, it can turn out 20
million doses.
More production with less staff.